← Browse variants

SIRT1 A>G

rs7895833

SIRT1 Intronic Variant β€” Guardian of Cellular Stress Response

SIRT1 (Sirtuin 1) is a NAD-dependent deacetylase | NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism with profound influence on aging, metabolism, neuroprotection, and mental health.

The sirtuin SIRT1 is expressed throughout the body, has broad biological effects and can significantly affect both cellular survival and longevity during acute and long-term injuries, which involve both oxidative stress and cell metabolism
. This intronic A>G variant (rs7895833) sits in a regulatory region of the SIRT1 gene | intronic variants can affect gene splicing, regulatory element binding, and ultimately protein expression levels and has been associated with expression levels of SIRT1 protein, particularly in aging populations.

The Mechanism

SIRT1 exerts a neuroprotective effect on various neurologic diseases through upregulation of SIRT1 which suppressed the expression levels of pro-inflammatory cytokines and increased the expression levels of superoxide dismutase 2 and catalase
.

A significant increase in the SIRT1 level in older people was observed with a significant positive correlation between SIRT1 level and age, with the oldest people carrying AG genotypes for rs7895833 having the highest SIRT1 level suggesting an association between rs7895833 SNP and lifespan longevity
. The G variant appears to modulate SIRT1 expression in a context-dependent manner β€” in some tissues and conditions increasing activity, in others potentially disrupting optimal function.

SIRT1 is a NAD+-dependent deacetylase that functions through nucleoplasmic transfer and is present in nearly all mammalian tissues, believed to deacetylate its protein substrates, resulting in neuroprotective actions, including reduced oxidative stress and inflammation, increased autophagy, increased nerve growth factors, and preserved neuronal integrity in aging or neurological disease
.

The Evidence

The G allele frequency varies considerably by ancestry. A Brazilian geriatric study of 216 patients | Costa Ribeiro H et al. Polymorphism rs7895833 in the SIRT1 gene and its association with dyslipidaemia in the elderly. Rev Esp Geriatr Gerontol. 2019 found the G allele at 42% frequency and associated it with dyslipidemia. A 3-year Korean pediatric study | Lee M et al. The Gender Association of the SIRT1 rs7895833 Polymorphism with Pediatric Obesity: A 3-Year Panel Study. J Nutrigenet Nutrigenomics. 2016 of 219 children found GA+AA genotypes associated with higher BMI and obesity risk, particularly in boys who showed reduced cholesterol improvements compared to GG carriers.

rs7895833 was associated with increased odds of developing multiple sclerosis under co-dominant, overdominant, dominant, and allelic genetic models
in a Lithuanian study of 250 MS patients.
rs3818292 and rs7895833 were associated with an increased risk of developing exudative age-related macular degeneration, with rs7895833 associated with increased risk in women after strict Bonferroni correction
.

Regarding mental health,
mice with brain-specific Sirt1 knockout decreased anxiety and developed resilience to depression induced by social defeat, while mice with global Sirt1 overexpression had elevated anxiety and increased susceptibility to depression
.

This behavioral phenotype was associated with a reduction in the levels of SIRT1 in the brain and in peripheral blood mononuclear cells, with peripheral blood mRNA expression of SIRT1 predicting the extent of behavioral despair only when depression-like behavior was induced by juvenile stress
. Studies have linked SIRT1 to depression mechanisms | Lu G et al. Role and Possible Mechanisms of Sirt1 in Depression. Oxid Med Cell Longev. 2018 through regulation of neuroinflammation, neurogenesis, and circadian control.

Practical Implications

SIRT1 is activated by NAD+ availability | NAD+ levels decline with age and can be supported through diet and supplementation, calorie restriction, exercise, and compounds like resveratrol (found in red wine and grapes).

Optimal SIRT1 activation is the most crucial step in the neuroprotection provided by resveratrol against cognitive impairment
. For G allele carriers, whose SIRT1 regulation may be altered, supporting NAD+ metabolism through lifestyle becomes particularly relevant.

The variant's association with both metabolic conditions (obesity, dyslipidemia) and neurological/psychiatric conditions (MS, depression, AMD) reflects SIRT1's pleiotropic role in cellular stress response. The complex age-dependent and tissue-specific effects mean that G carriers may benefit from supporting SIRT1 function through multiple pathways | including NAD+ precursors, calorie restriction mimetics, and antioxidant support rather than relying on a single intervention.

Interactions

rs7895833 does not act in isolation within the SIRT1 gene.

The rs3818292-rs3758391-rs7895833 haplotype G-T-G was associated with increased odds of exudative AMD
. Other SIRT1 variants including rs3818292 (intronic), rs3758391 (promoter), and rs7069102 (intron 4) have been studied in combination with rs7895833, showing that multiple regulatory variants within SIRT1 interact to modulate protein expression and disease risk. These compound effects are particularly pronounced in aging-related conditions where SIRT1's protective functions become critical.

All genotypes

AA normal

Typical SIRT1 expression and oxidative stress response

You carry two copies of the more common A allele at this SIRT1 regulatory site. About 34% of people of European descent share this genotype. SIRT1 is a master regulator of cellular stress response, longevity pathways, and neuroprotection through its NAD-dependent deacetylase activity. Your AA genotype is associated with standard SIRT1 expression patterns without the regulatory alterations seen with the G variant.

AG intermediate

Mixed SIRT1 regulation with context-dependent effects

You carry one copy of each variant. About 49% of Europeans share this genotype, making it the most common pattern. Studies show interesting age-dependent effects β€” elderly AG carriers may have higher SIRT1 levels associated with longevity, but younger AG carriers show increased risk for obesity and metabolic conditions. This suggests the G variant's effects on SIRT1 regulation change across the lifespan or vary by tissue and metabolic context.

GG reduced

Modified SIRT1 expression with increased vulnerability to metabolic and inflammatory conditions

You carry two copies of the G variant. About 17% of Europeans share this genotype, making it less common. The GG genotype has been most strongly associated with disease risk across multiple studies β€” including increased obesity risk in children, dyslipidemia in elderly, multiple sclerosis, and age-related macular degeneration. However, paradoxically, some data suggests certain GG carriers (particularly in specific age groups or with compound genotypes) may have altered SIRT1 regulation that could be either protective or detrimental depending on environmental factors.